MHRA publishes 2026 performance data to improve transparency

25th May 2026

Summary:
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its latest performance data, providing insight into how efficiently it is delivering its regulatory responsibilities. The data covers areas such as timelines for clinical trial approvals, licensing decisions, and safety assessments, aiming to improve transparency and accountability. By making this information publicly available, the MHRA seeks to demonstrate progress, identify areas for improvement, and support the UK’s position as an attractive location for life sciences innovation.

Link: https://www.gov.uk/government/publications/mhra-performance-data

Back to Recent News